Babesiosis poses significant risks of adverse outcomes in individuals with immunocompromising conditions (IC) and asplenia/hyposplenia (AH). This study compares clinical outcomes between these vulnerable groups and immunocompetent patients.

This retrospective cohort of 113 immunocompetent and 112 immunocompromised and/or asplenic/hyposplenic patients found higher complication, mortality, and r